Diabetics barred from starting Avandia trial
Thursday, July 22, 2010 - 09:28
in Health & Medicine
U.S. federal health officials are barring new patients from enrolling in a safety study of GlaxoSmithKline's controversial Type 2 diabetes pill Avandia.